Uprima of Abbott found to be safe in patients with cardiac disorder

Published: 2002-05-13 06:57:00

Updated: 2002-05-13 06:57:00

In the recent forum in Hong Kong, the data of 500 doctors from several countries of Pacific-rim countries, Asia and Africa demonstrated that Uprima of Abbbott had a better tolerability in patients with impotence taking the concurrent therapy of nitrate for the treatment of cardiac disorder. Those...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK